140
Participants
Start Date
December 28, 2022
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
deucrictibant selected dose
deucrictibant soft capsule for oral use
Study site, San Juan
Study site, San Juan
Study site, Budapest
Study site, Vienna
Study site, Sofia
Study site, Sofia
Study site, Campbelltown
Study site, Salta
Study site, Cape Town
Study site, Graz
Study site, Riyadh
Study site, Berlin
Study site, Hershey
Study site, Milan
Study site, Milan
Study site, Chevy Chase
Study site, Lund
Study site, Lübeck
Study site, Madrid
Study site, Istanbul
Study site, Padua
Study site, Birmingham
Study site, Grenoble
Study site, Daegu
Study site, Detroit
Study site, Frankfurt am Main
Study site, Frankfurt am Main
Study site, St Louis
Study site, Little Rock
Study site, Dallas
Study site, Paris
Study site, Ashkelon
Study site, Napoli
Study site, Colorado Springs
Study site, Scottsdale
Study site, Palermo
Study site, Santa Monica
Study site, San Diego
Study site, Walnut Creek
Study site, Catania
Study site, Boston
Study site, Buenos Aires
Study site, Salvador
Study site, Ribeirão Preto
Study site, Santo André
Study site, São Paulo
Study site, Edmonton
Study site, Montreal
Study site, Hong Kong
Study site, Brno
Study site, Roma
Study site, Hiroshima
Study site, Kanagawa
Study site, Osaka
Study site, Tokyo
Study site, Tokyo
Study site, Amsterdam
Study site, Krakow
Study site, Seoul
Study site, Barcelona
Study site, Barcelona
Study site, Ankara
Study site, London
Pharvaris Netherlands B.V.
INDUSTRY